In the News
Reimagine Care and Memorial Hermann Health System Partner to Advance Cancer Care at Home
On Tuesday, July 25, Reimagine Care – the nation’s top cancer care service provider for at-home treatment – announced a brand-new partnership with Memorial Hermann Health System, based out of Houston, TX. The partnership will allow the companies to offer 24/7 care via phone, text, video, and in-home support from...
Montage Health Selects Xealth to Drive Digital Health Strategy
Montage Health, a California-based non-profit network, announced on Tuesday that it has chosen the Xealth digital health platform as its new primary medical system. Known for its prominent role in the digital health space, Xealth provides a variety of services to its users including centralized medical technology,...
Diversity in Clinical Trials: A Regulatory Imperative
A recent study has shown that Americans of color participating in clinical trials received significantly less inclusion than white Americans. This analysis, conducted by Komodo Health, shows that 85% of participants in oncology trials were white over the past five years. For reference, black participants made up only...
Reimagine Care Welcomes Dan Nardi, Healthcare Industry Leader, as New CEO
Reimagine Care has announced that Dan Nardi will serve as its new Chief Executive Officer, effective July 10, 2023. Nardi replaces co-founder Dr. Aaron Gerber as CEO. Previously, Nardi served as Carrum Health’s Chief Operating Officer and Livongo’s Vice President of Operations. He brings to the role a deep...
Kathleen Bresette named chief revenue officer at RxLightning
RxLightning has hired Kathleen Bresette as its first chief revenue officer. Bresette’s experience in the health care industry is expansive. Most recently, she served as vice president of business development and client strategy at DrFirst Inc. She was also previously the chief revenue officer for Aptus Health (then...
Merck Digital Sciences Studio’s SciMar ONE is already demonstrating early value
Last year, McKesson Ventures joined a group of funders including Merck, Microsoft, the Global Health Innovation Fund, Northpond Ventures, and the New Jersey Institute of Technology to bring to life a “founder-friendly” startup accelerator for companies in the biopharma industry. That accelerator is the Merck Digital...
Lessons from Farzad Mostashari, CEO and Co-Founder of Aledade, on Empowering Independent Primary & Value-Based Care
Aledade CEO and Co-Founder Farzad Mostashari was recently a guest on the Pear Healthcare Playbook podcast. In the talk, Mostashari discusses his journey to healthcare, how he started Aledade, the importance of independent physicians in value-based care, and how Aledade scaled as a profitable health tech company, and...
Clinical ink Appoints Andrew Kraus as Chief Technology Officer
Clinical Ink, a global life science technology company, has announced the appointment of Andrew Kraus as chief technology officer. In this role, Kraus will lead the development of the company’s expanding technology portfolio to support clinical trials. Kraus is an accomplished global healthcare executive with a...
McKesson Ventures’ Dave Schulte Named One of Healthcare’s Top 25 Investors
McKesson Ventures Managing Director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance and who are recognized as leaders by portfolio company CEOs, industry...
Koneksa Announces Partnership with Beacon Biosignals for Clinical Trials in Sleep and Neurologic Disorders Using EEG Biomarkers
Koneksa has announced a partnership with Beacon Biosignals, a computational neurodiagnostics company, to launch a clinical trial to investigate the integration of Beacon’s at-home electroencephalogram (EEG) into the Koneksa Neuroscience Solution Toolkit. The Beacon platform unlocks longitudinal, at-home EEG...